Eighteenth edition of Fujio Cup Quiz won by Kasturba Medical College, India in the NCRM NICHE 2023 international stem cell meeting.

TOKYO -- Businesswire -- Harshavardhan Sai Sadineni and Srived Meda of Kasturba Medical College, Manipal, India, won the XVIII Fujio Cup Quiz (FCQ) on Stem cells and Regenerative medicine (RM) in the NCRM NICHE 2023; Sri Ramachandra Institute for Higher Education and Research, India and Institut Teknologi Bandung, Indonesia emerged as runners and joined the team of FCQ elites, a privilege bestowed on those who reach the final stage of the multi-level international contest including a quiz in RM, thereby qualifying to nominate the candidate(s) to Edogawa NICHE Prize, instituted in 2018. The Edogawa NICHE Prize (https://bit.ly/45InU7Y) awardee of 2020, Dr John Craig Venter will deliver his lecture at the UHN Ajmera Transplant Center, on the 25th October 2023, in conjunction with the Training Program in Regenerative Medicine (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.regenmedcanada.com%2F&esheet=53631072&newsitemid=20231017068457&lan=en-US&anchor=Training+Program+in+Regenerative+Medicine&index=3&md5=13102b5fa6a1a157401c26dd100a52c3) (TPRM) at the University of Toronto, co-hosted by German Society for Stem Cell Research (GSZ).

FCQ is an active knowledge gaining event in RM started in 2006 in India, as a part of NCRM NICHE (https://www.ncrmniche.org/), the inaugural anniversary commemorative event of Nichi-in Centre for Regenerative medicine (NCRM), held every October, conducted in Tokyo 2017~2019, and now virtually. NCRM NICHE has triggered novel ideas and collaborations yielding cutting edge solutions in cell therapies such as the Buccal epithelium Expanded and Encapsulated in Scaffold-Hybrid Approach to Urethral Stricture (BEES HAUS) with clinical studies (https://onlinelibrary.wiley.com/doi/10.1111/iju.13852) of safety & efficacy and preclinical evidence (https://linkinghub.elsevier.com/retrieve/pii/S2352320421000420), tissue engineering technologies for transplant suitable human chondrocytes for cartilage repair (https://linkinghub.elsevier.com/retrieve/pii/S0968016021000661) with age reversal (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fdoi.org%2F10.1038%2Fs41598-021-93607-9&esheet=53631072&newsitemid=20231017068457&lan=en-US&anchor=age+reversal&index=8&md5=f8469e362c6c9cc66b0cc3dfb123f4e1) in vitro, optimized solutions for transport of cells (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fdoi.org%2F10.1089%2Fbio.2021.0079&esheet=53631072&newsitemid=20231017068457&lan=en-US&anchor=transport+of+cells&index=9&md5=c40a5a0cd81f01224ea55b075e651fe6) and tissues for processing (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fdoi.org%2F10.1089%2Fbio.2021.0079&esheet=53631072&newsitemid=20231017068457&lan=en-US&anchor=transport+of+cells&index=9&md5=c40a5a0cd81f01224ea55b075e651fe6) between hospitals and cell processing facilities. Through a global inter-disciplinary networking, disease modifying adjunct solutions developed for unmet needs viz., Duchenne muscular dystrophy (DMD) (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fdoi.org%2F10.1038%2Fs41598-023-44330-0&esheet=53631072&newsitemid=20231017068457&lan=en-US&anchor=Duchenne+muscular+dystrophy+%28DMD%29&index=11&md5=42870d36153ffc3e72fe3716b18b13d2), multiple sclerosis (MS) (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fdoi.org%2F10.1101%2F2023.05.14.23289953&esheet=53631072&newsitemid=20231017068457&lan=en-US&anchor=multiple+sclerosis+%28MS%29&index=12&md5=7431172cf8878c97ae32ee548e58d093), Autism spectrum disorders (ASD) (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fcontent.iospress.com%2Farticles%2Fjournal-of-alzheimers-disease%2Fjad220388&esheet=53631072&newsitemid=20231017068457&lan=en-US&anchor=Autism+spectrum+disorders+%28ASD%29%2C&index=13&md5=d7b1fc1890d8f436d31c18f634d5c72d), and Parkinson’s disease (PD) (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fdoi.org%2F10.1101%2F2023.04.14.23288571&esheet=53631072&newsitemid=20231017068457&lan=en-US&anchor=Parkinson%26%238217%3Bs+disease+%28PD%29&index=14&md5=d10190e0160f49919cd7be1d9cad5fb6), were presented in the Inter-disciplinary Conclave (IDC).

Prof. Dr. Mihai G. Netea, Radboud University Medical Center, Netherlands, talked on Trained immunity and innate host defense, Dr Shojiro Katoh, President, Edogawa Hospital, on Novel tissue engineering technology enhancing cell therapies for cartilage repair, Mr. Yasutoshi Nishikawa, on Biomaterials for bone reconstruction and Dr Dedeepiya Devaprasad, on Gut microbiome (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fdx.doi.org%2F10.1136%2Fbmjgast-2022-000985&esheet=53631072&newsitemid=20231017068457&lan=en-US&anchor=Gut+microbiome&index=17&md5=b62d431e9875696acb0d6377dd54b4dd), Gut-brain-axis (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9277691%2F&esheet=53631072&newsitemid=20231017068457&lan=en-US&anchor=Gut-brain-axis&index=18&md5=5c5fa9e6b1b7e1711ebe6f8892fceaf0) & Brain health, moderated by Prof. Dr. Jurgen Hescheler, University of Cologne, Germany.

NCRM with cell biology and biomaterial laboratories, in collaboration with academic and industry partners in Japan are researching on the basic origin of diseases at cellular level taking cues from immune system evolution across phylogeny, in vitro culture systems and in vivo biological responders.

이 뉴스는 기업·기관·단체가 뉴스와이어를 통해 배포한 보도자료입니다.

출처:GN Corporation Co., Ltd.

보도자료 통신사 뉴스와이어(www.newswire.co.kr) 배포